Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control

Clinics in Chest Medicine
Giovanni Battista MiglioriChristoph Lange

Abstract

The emergence of multidrug-resistant (MDR) and, more recently, of extensively drug resistant (XDR) strains of Mycobacterium tuberculosis is a real threat to achieve tuberculosis (TB) control and elimination globally. More than 510,000 new cases of MDR-TB occur each year and XDR-TB cases are recognized in every setting where there has been the capacity to detect them, particularly in Eastern Europe. MDR- and XDR-TB control in Europe and the United States are heavily affected by what happens globally, as the majority of cases occurring in these countries originate in high TB-burden areas of the world. Scaling-up of culture- and drug susceptibility testing capacities and the expanded use of high-technology assays for rapid determination of resistance represent the prerequisites to achieve better control of MDR- and XDR-TB. Most cases with MDR- and XDR-TB in Europe and the United States can be treated successfully if well-designed regimens based on available second- and third-line anti-TB drugs are used and surgical options are carefully considered. Nevertheless, the development of new (more effective and less toxic) drugs to treat patients infected by MDR- and XDR-TB strains with or without active disease are urgently needed. Adhe...Continue Reading

References

Mar 1, 1990·The American Review of Respiratory Disease·M D IsemanM Pomerantz
Oct 5, 1995·The New England Journal of Medicine·E E TelzakG Turett
Jan 1, 1994·Revue D'épidémiologie Et De Santé Publique·H Rieder, V Schwoebel
Feb 25, 1993·The New England Journal of Medicine·T R FriedenS W Dooley
Feb 25, 1993·The New England Journal of Medicine·M GobleC R Horsburgh
Jan 1, 1996·American Journal of Respiratory and Critical Care Medicine·M M ParkW N Rom
Nov 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G S TurettB A Fazal
Mar 1, 1997·Clinics in Chest Medicine·M Pomerantz, J M Brown
Aug 3, 1999·American Journal of Respiratory and Critical Care Medicine·M Flament-SaillourJ Grosset
Sep 15, 1999·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·S W SungJ H Kim
May 18, 2000·JAMA : the Journal of the American Medical Association·M A EspinalM C Raviglione
Jul 21, 2001·The New England Journal of Medicine·K TahaoğluN Kapakli
Jan 18, 2002·Antimicrobial Agents and Chemotherapy·Stephen H Gillespie
Jan 20, 2004·Tropical Medicine & International Health : TM & IH·Richard J Coker
Jan 27, 2004·American Journal of Respiratory and Critical Care Medicine·Edward D ChanMichael D Iseman
Oct 1, 2004·The Journal of Thoracic and Cardiovascular Surgery·Yuji ShiraishiNobumasa Takahashi
Mar 17, 2005·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·M CasalV Jarlier
Jun 9, 2005·JAMA : the Journal of the American Medical Association·Reuben M GranichJennifer Flood
Dec 13, 2005·BMJ : British Medical Journal·Richard CokerFrancis Drobniewski
Mar 7, 2006·The Journal of Thoracic and Cardiovascular Surgery·Altan KirKemal Tahaoglu
Mar 21, 2006·Lancet·Mario C Raviglione, Mukund W Uplekar
Jul 14, 2006·The European Respiratory Journal·C-Y ChiangT-P Lin
Jul 18, 2006·The Journal of Infectious Diseases·Matteo ZignolChristopher Dye
Nov 1, 2006·Emerging Infectious Diseases·Eva NathansonMario C Raviglione
Mar 28, 2007·Asian Cardiovascular & Thoracic Annals·Rishendran Naidoo
Aug 30, 2007·The Journal of Infectious Diseases·Melvin K Spigelman
Aug 2, 2007·The European Respiratory Journal·G B MiglioriUNKNOWN Stop TB Italia Group
Aug 2, 2007·The European Respiratory Journal·T H Holtz, J P Cegielski
Oct 5, 2007·Expert Review of Anti-infective Therapy·Alberto MatteelliMario Raviglion
Nov 9, 2007·PLoS Medicine·Carole D MitnickWilliam Burman
Jul 10, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yong Soo KwonWon-Jung Koh
Jul 12, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ritu BanerjeeJennifer Flood
Aug 8, 2008·The European Respiratory Journal·Z MorM F Iademarco
Aug 9, 2008·The New England Journal of Medicine·Carole D MitnickMercedes C Becerra
Aug 9, 2008·The New England Journal of Medicine·Edward D ChanMichael D Iseman
Aug 16, 2008·American Journal of Respiratory and Critical Care Medicine·Doh Hyung KimTae Sun Shim
Aug 30, 2008·BMJ : British Medical Journal·Alison GrantGuy Thwaites

❮ Previous
Next ❯

Citations

Dec 22, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·W WangB Xu
Jan 5, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·V AmanatidouM N Tsolia
Dec 16, 2011·Bulletin de la Société de pathologie exotique·D MounguenguiP L'her
Mar 20, 2010·The Pediatric Infectious Disease Journal·Beate Kampmann
Feb 8, 2011·The Pediatric Infectious Disease Journal·Mona Al-DabbaghTobias R Kollmann
Mar 17, 2012·Nuclear Medicine Communications·Mike SathekgeChristophe Van de Wiele
Mar 27, 2010·Respirology : Official Journal of the Asian Pacific Society of Respirology·Chen-Yuan ChiangGiovanni Battista Migliori
Apr 23, 2010·Respirology : Official Journal of the Asian Pacific Society of Respirology·Philip Lobue, Dick Menzies
Sep 24, 2011·American Journal of Public Health·Jonathan E Suk, Jan C Semenza
Mar 12, 2011·Emerging Infectious Diseases·Shenjie TangHeping Xiao
Nov 3, 2010·The American Journal of Tropical Medicine and Hygiene·Gustavo FerrerManuel Rivera
Jun 16, 2010·Tropical Medicine & International Health : TM & IH·Giovanni Battista MiglioriAlimuddin Zumla
Oct 25, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S HargreavesJ S Friedland
Mar 24, 2009·Tropical Medicine & International Health : TM & IH·Haileyesus GetahunPaul Nunn
Mar 11, 2010·Tropical Medicine & International Health : TM & IH·Webster MavhuJeremiah Chikovore
Jul 28, 2011·Scandinavian Journal of Immunology·T Qidwai, F Khan
May 16, 2012·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Solomon Abebe YimerCarol Holm-Hansen
Jul 20, 2013·Journal of the American Veterinary Medical Association·Rebecca L SmithYrjo T Grohn
Sep 26, 2015·Journal of the Pediatric Infectious Diseases Society·Kirsty Le DoareMike Sharland
Sep 21, 2012·Journal of Clinical Microbiology·Luisa Maria NietoDick van Soolingen
Jun 3, 2010·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Allan M ConcejeroBruno Jawan
Apr 8, 2014·The Medical Journal of Australia·Joshua R FrancisJustin Waring
Nov 19, 2010·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Marcos Abdo ArbexFernando Augusto Fiúza de Mello
Nov 19, 2010·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Marcos Abdo ArbexFernando Augusto Fiúza de Mello
Mar 13, 2021·BMC Public Health·Lesley-Ann Lynnath CannonDaniel Ter Goon
May 17, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Mike SathekgeChristophe Van de Wiele
Jun 30, 2021·Current Opinion in Pharmacology·Michele MondoniGiovanni Sotgiu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

© 2022 Meta ULC. All rights reserved